J.J. Hardy headed to DL with groin injury

5 Comments

Orioles shortstop J.J. Hardy has already been slumping and now Rich Dubroff of CSNMidAtlantic.com reports that he’s headed to the disabled list with a left groin injury.

The injury has bothered Hardy for a few days. The 33-year-old was held out of today’s lineup against the Twins, but entered the game as a defensive replacement in the ninth inning before leaving for a pinch-runner in the 11th. Hardy admitted to Dan Connolly of the Baltimore Sun after the game that he felt some discomfort while running and walking, so it was decided that a trip to the disabled list is the best course of action.

Hardy is still very good defensively, but he continues to decline at the plate. He’s hitting just .145 this month and .222/.253/.315 with seven home runs and 32 RBI on the year.

Ryan Flaherty figures to get most of the playing time at shortstop with Hardy sidelined. It’s worth noting that Manny Machado made his first major league appearance at shortstop in the 12th inning today after Hardy left the game. He committed an error which opened the door for the winning run to score.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.